Search results
Author(s):
Kazuya Hosokawa
,
Abe Kotaro
Added:
2 years ago
AHA 2023 — Dr Kazuya Hosokawa and Dr Abe Kotaro (Kyushu University Hospital, JP) join us to share the findings of the KABUKI trial (NCT04730037). The aim of KABUKI (Daiichi Sankyo) is to assess whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).This investigator-initiated, multicenter, phase 3…
View more
Pathophysiology, Mechanism, Diagnosis and Management of PAH
Author(s):
Apoorva Gangavelli
,
Ronaldo C Fabiano
,
Mariam Riad
,
et al
Added:
2 months ago
Review Article
Cardio-obstetrics in the CICU: An Introductory Guide
Author(s):
Jenna Skowronski
,
Eleanor Christenson
,
Kayle Shapero
,
et al
Added:
1 year ago
Review Article